PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7274559

The Belgian plasmapheresis programme.

C Vermylen
View original source ↗Export metadata ↓

Abstract

In Belgium 6000 non-remunerated donors regularly give plasma by the double plasmapheresis technique. The donation frequency is once every two weeks. Thus 75 000-80 000 liters of plasma are collected annually. This figure represents 7 500-8 000 liters of plasmapheresis plasma/10(6) inhabitants. Furthermore 5000 liters of plasma/10(6) inhabitants are recovered from whole blood (60% utilization of erythrocytes-concentrates). The 13 000 liters of plasma/10(6) inhabitants allow the country to cover all the national needs of albumin, coagulation factors and immunoglobulins. The programme is fully described and presented as a unique model of national self-sufficiency avoiding red cells wastage, and being entirely based on non-remunerated donors.

Explore related subjects

BelgiumBlood BanksHumansPlasmapheresisTime FactorsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Vermylen. 1980. The Belgian plasmapheresis programme.. https://pubmed.ncbi.nlm.nih.gov/7274559/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

The future of precision oncology and artificial intelligence in Belgium: scenarios and policy responses.

PURPOSE: Precision medicine, also known as personalized medicine, enables the provision of tailored health services to patients. In the prevention, early detection, and treatment of cancers, precision medicine is highly promising, given the increasing use of genomic profiling for diagnosis and adapting therapies in several tumor types. Artificial Intelligence (AI) can support this process by analyzing vast amounts of relevant data. However, high-quality data and financial investments in the health system are essential for the implementation of precision medicine and AI solutions in routine cancer care. DESIGN/METHODOLOGY/APPROACH: Building on the quantitative outcomes of a foresight exercise published in another study, this article collects qualitative data to gain more detailed insights into the future of precision oncology in Belgium and discusses the role of AI in this field. It reports the results of a series of expert workshops, focusing on four hypothetical future scenarios that are centered around technological and economic issues that must be overcome for the widespread use of precision oncology in Belgium. FINDINGS: The study concludes that all four scenarios discussed in the workshops would require supportive policy measures in Belgium, which should go beyond mere technological and economic considerations, such as involving patient associations and the public in policy design or creating multi-disciplinary expert groups for precision medicine. ORIGINALITY/VALUE: To the best of our knowledge, this is the first study to employ foresight methodology to illustrate possible future scenarios, scrutinize feasible approaches for implementing precision oncology in Belgium, and discuss the use of AI in this context.

Belgium↗